Complete Filing Data
Adecoagro S.A. reported Cash And Cash Equivalents of $211.24 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Adecoagro S.A. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profit Loss From Operating Activities | $182.3M | $241.6M | $249.8M | $278.0M | $189.1M | $121.4M | $156.5M | $129.6M | $184.6M | $95.4M |
| Profit Loss Before Tax | $35.1M | $305.4M | $135.4M | $174.6M | $13.4M | $21.2M | -$24.3M | $10.0M | $27.2M | -$12.3M |
| Profit Loss Attributable To Owners Of Parent | $92.3M | $226.3M | $108.1M | $130.7M | $412.0K | -$772.0K | -$24.6M | $13.2M | $11.6M | -$5.6M |
| Profit Loss Attributable To Noncontrolling Interests | -$239.0K | $430.0K | $468.0K | $48.0K | $658.0K | $1.1M | $1.4M | $1.8M | $2.7M | $1.2M |
| Profit Loss | $92.1M | $226.7M | $108.6M | $130.7M | $1.1M | $342.0K | -$23.2M | $15.0M | $14.3M | -$4.4M |
| Other Comprehensive Income Net Of Tax Exchange Differences On Translation | $396.4M | -$222.2M | $98.7M | $121.1M | -$79.0M | -$27.8M | -$121.3M | -$21.2M | $32.9M | -$178.1M |
| Other Comprehensive Income Net Of Tax Cash Flow Hedges | $17.1M | $27.7M | $16.1M | $29.8M | -$14.4M | -$19.4M | -$32.2M | $12.6M | $100.6M | -$94.9M |
| Other Comprehensive Income | $145.1M | -$71.6M | $67.9M | $14.3M | -$63.9M | -$79.2M | $252.4M | -$8.6M | $133.5M | -$273.0M |
| Income Tax Expense Continuing Operations | -$57.0M | $78.7M | $26.8M | $43.8M | $12.3M | $20.8M | -$1.0M | -$5.0M | $12.9M | -$8.0M |
| Gross Profit | $434.8M | $415.4M | $465.6M | $484.2M | $335.6M | $286.4M | $198.6M | $238.5M | $310.3M | $185.7M |
| General And Administrative Expense | $103.9M | $70.3M | $84.3M | $69.8M | $53.4M | $57.2M | $56.1M | $57.3M | $50.8M | $48.4M |
| Cost Of Sales | $1.20B | $973.2M | $1.08B | $855.0M | $611.9M | $671.2M | $610.0M | $766.7M | $678.6M | $557.8M |
| Comprehensive Income Attributable To Owners Of Parent | $234.2M | $155.0M | $174.7M | $147.3M | -$63.4M | -$75.4M | $213.6M | $6.3M | $147.4M | -$275.1M |
| Comprehensive Income Attributable To Noncontrolling Interests | $3.1M | $52.0K | $1.8M | -$2.3M | $529.0K | -$3.4M | $15.5M | $28.0K | $374.0K | -$2.3M |
| Comprehensive Income | $237.2M | $155.1M | $176.5M | $145.0M | -$62.8M | -$78.8M | $229.2M | $6.4M | $147.8M | -$277.3M |
| Income Taxes Paid Refund Classified As Operating Activities | $7.3M | $1.3M | $8.1M | $2.2M | $2.1M | $2.3M | $1.9M | $2.9M | $1.1M | $230.0K |
| Income Tax Relating To Cash Flow Hedges Of Other Comprehensive Income | -$7.1M | -$8.5M | -$7.3M | -$2.5M | $5.7M | $6.8M | $11.3M | -$8.7M | $49.1M | -$49.1M |
| Adjustments For Reconcile Profit Loss | $515.1M | $507.0M | $465.0M | $512.7M | $344.4M | $340.0M | $239.1M | $221.3M | $308.1M | $157.0M |
| Adjustments For Income Tax Expense | -$57.0M | $78.7M | $26.8M | $43.8M | $12.3M | $20.8M | -$1.0M | -$5.0M | $12.9M | -$8.0M |
| Other Comprehensive Income Net Of Tax Gains Losses On Revaluation | -$268.4M | $122.8M | -$46.9M | -$136.6M | $29.5M | -$31.9M | $405.9M | $0.00 | $0.00 | |
| Income Tax Relating To Changes In Revaluation Surplus Of Other Comprehensive Income | $145.0M | -$63.0M | -$25.3M | -$10.0M | $11.8M | $10.5M | $139.2M | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $211.2M | $339.8M | $230.7M | $199.8M | $336.3M | $290.3M | $273.6M | $269.2M | $158.6M | $198.9M | $113.8M |
| Property Plant And Equipment | $1.55B | $1.55B | $1.57B | $1.42B | $1.36B | $1.49B | $1.48B | $831.4M | $814.9M | $696.9M | |
| Gain Losses On Initial Recognition Of Biological Assets And Change In Fair Value Estimates Of Biological Assets For Current Period | $143.1M | $87.9M | $215.9M | $227.7M | $122.7M | $68.6M | $16.2M | $63.2M | $125.5M | $54.5M | |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $260.2M | $241.6M | $217.8M | $199.3M | $168.5M | $252.5M | $207.1M | $198.6M | $132.4M | $141.5M | |
| Purchase Of Intangible Assets Classified As Investing Activities | $1.2M | $1.3M | $3.4M | $1.9M | $1.1M | $8.6M | $3.3M | $2.1M | $1.2M | $1.2M | |
| Purchase Of Biological Assets | $1.9M | $511.0K | $9.1M | $11.8M | $7.3M | $5.0M | $5.7M | $1.7M | $1.7M | $306.0K | |
| Cash Payments For Futures Contracts Forward Contracts Option Contracts And Swap Contracts Classified As Operating Activities | -$28.7M | -$36.9M | -$40.2M | -$52.7M | -$24.4M | -$15.6M | -$38.1M | -$20.8M | -$85.2M | -$32.7M | |
| Cash Flows From Used In Operations | $335.6M | $436.2M | $378.1M | $350.9M | $259.2M | $324.4M | $220.4M | $240.0M | $256.6M | $145.4M | |
| Cash Flows From Used In Operating Activities | $328.3M | $434.9M | $370.0M | $348.7M | $257.1M | $322.1M | $218.5M | $237.1M | $255.4M | $145.2M | |
| Cash Flows From Used In Investing Activities | -$231.6M | -$111.6M | -$299.3M | -$175.2M | -$121.9M | -$249.6M | -$175.1M | -$188.3M | -$122.0M | -$125.1M | |
| Cash Flows From Used In Financing Activities | -$274.0M | -$208.7M | -$23.6M | -$303.1M | -$53.9M | -$37.9M | -$20.9M | $70.2M | -$181.7M | $92.4M | |
| Adjustmentsfor Losses Gainson Disposalof Farmlandsand Other Assets | -$6.1M | -$6.3M | $0.00 | $0.00 | -$2.1M | -$1.4M | -$36.2M | $0.00 | $0.00 | -$7.9M | |
| Adjustments For Increase Decrease In Trade Account Payable | -$100.3M | -$43.9M | -$64.5M | -$1.5M | $828.0K | $13.1M | $31.1M | $6.6M | $39.1M | -$9.9M | |
| Adjustments For Increase Decrease In Other Operating Payables | $1.1M | $803.0K | -$290.0K | $74.0K | $380.0K | -$351.0K | -$430.0K | $855.0K | $1.2M | $21.0K | |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | $4.1M | $15.7M | $7.7M | $4.9M | $4.1M | $2.6M | $5.9M | $2.0M | $3.1M | $5.0M | |
| Adjustments For Decrease Increase In Trade Account Receivable | -$68.3M | $3.7M | -$60.8M | -$40.4M | -$55.2M | -$17.7M | -$65.9M | -$9.5M | -$31.0M | -$2.3M | |
| Adjustments For Decrease Increase In Other Assets | -$2.1M | -$37.0K | -$1.1M | -$303.0K | -$35.0K | -$210.0K | -$777.0K | $2.0K | $83.0K | -$871.0K | |
| Adjustments For Decrease Increase In Biological Assets | -$38.9M | -$23.4M | -$3.7M | $7.6M | -$10.3M | -$27.0M | $3.0M | -$18.0M | -$23.7M | -$20.2M | |
| Increase Decrease Dueto Harvest Biological Assets | -$28.4M | $1.8M | -$22.3M | -$12.9M | $7.0M | $1.8M | -$909.0K | $8.9M | -$5.8M | ||
| Gains Losseson Fair Value Adjustment Biological Assets Non Harvested | -$18.3M | -$17.7M | $44.9M | $11.3M | $33.0M | $1.7M | -$30.3M | $14.6M | $9.8M | ||
| Rightofuse Assets | $373.8M | $406.7M | $360.2M | $260.8M | $209.7M | $238.1M | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | $23.3M | $33.2M | $9.9M | $8.1M | $16.0M | $5.8M | $31.5M | $0.00 | $3.4M | $12.6M |
| Proceeds From Other Longterm Assets Classified As Investing Activities | $2.3M | $4.1M | $2.8M | $2.9M | $3.5M | $2.7M | $1.7M | $2.8M | $2.2M | $1.3M |
| Proceeds From Noncurrent Borrowings | $126.8M | $7.7M | $41.1M | $31.0M | $116.0M | $108.3M | $45.5M | $232.4M | $167.4M | $299.3M |
| Payments To Acquire Or Redeem Entitys Shares | 66.9M | 26.2M | 36.8M | 66.5M | 4.4M | 4.3M | 15.7M | 38.4M | 4.8M | 320.0K |
| Increase Decrease In Cash And Cash Equivalents | -$177.2M | $114.6M | $47.2M | -$129.7M | $81.3M | $34.6M | $22.6M | $119.0M | -$48.3M | $112.5M |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | $48.7M | -$5.5M | -$16.3M | -$6.8M | -$35.3M | -$18.0M | -$18.1M | -$8.3M | $8.0M | -$27.4M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Diluted Earnings Loss Per Share | $0.90 | $2.11 | $0.98 | $1.13 | $0.00 | $-0.01 | $-0.21 | $0.11 | $0.09 | $-0.05 |
| Basic Earnings Loss Per Share | $0.90 | $2.11 | $0.98 | $1.14 | $0.00 | $-0.01 | $-0.21 | $0.11 | $0.10 | $-0.05 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividends Paid | $35.0M | $35.0M | $35.0M | $298.0K | $2.5M | $497.0K | $408.0K | $2.9M | ||
| Selling Expense | $153.5M | $129.1M | $143.5M | $117.7M | $95.1M | $107.0M | $90.2M | $95.4M | $80.7M | $70.3M |
| Other Operating Income Expense | $4.8M | $25.6M | $1.9M | -$18.8M | $2.0M | -$822.0K | $104.2M | $43.8M | $5.8M | $31.1M |
| Investment Property | $33.5M | $33.4M | $33.3M | $32.1M | $31.2M | $34.3M | $40.7M | $42.3M | $44.6M | $4.8M |
| Finance Income Cost | -$147.2M | $63.8M | -$114.4M | -$103.5M | -$175.7M | -$100.2M | -$180.8M | -$119.6M | -$157.4M | -$107.7M |
| Finance Income | $16.8M | $157.1M | $25.3M | $36.7M | $26.1M | $9.9M | $8.4M | $11.7M | $8.0M | $9.2M |
| Finance Costs | $166.4M | $122.1M | $137.6M | $151.7M | $213.8M | $202.6M | $163.9M | $131.3M | $165.4M | $116.9M |
| Repayments Of Noncurrent Borrowings | $105.7M | $24.1M | $14.0M | $108.4M | $34.8M | $101.8M | $124.3M | $602.7M | $277.9M | $165.5M |
| Repayments Of Current Borrowings | $239.9M | $420.3M | $192.6M | $328.5M | $233.5M | $131.5M | $190.6M | $64.8M | $272.0M | $208.3M |
| Purchase Of Treasury Shares | 66.9M | 26.2M | 36.8M | 66.5M | 4.4M | 4.3M | 15.7M | 38.4M | 4.8M | 319.0K |
| Proceedsfrom Shortterm Borrowings Classifiedas Financing Activities | $169.9M | $448.5M | $347.9M | $286.1M | $207.2M | $194.0M | $318.1M | $106.7M | $257.4M | $211.0M |
| Interest Received Classified As Investing Activities | $7.8M | $62.1M | $5.2M | $16.7M | $25.4M | $7.2M | $7.7M | $11.2M | $7.7M | $8.2M |
| Interest Paid Classified As Financing Activities | $24.6M | $55.5M | $44.8M | $53.6M | $60.0M | $54.0M | $50.0M | $41.6M | $48.4M | $48.4M |
| Increase Decrease Through Sharebased Payment Transactions | $4.8M | $6.1M | $7.6M | $5.4M | $3.3M | $3.6M | $3.9M | $5.6M | $4.8M | $4.4M |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | $736.0K | $0.00 | $358.0K | $311.0K | $2.4M | $905.0K | $1.2M | $1.7M | $0.00 | $0.00 |
| Adjustments For Unrealised Foreign Exchange Losses Gains | $37.6M | -$90.9M | -$19.3M | -$18.9M | $109.3M | $108.5M | $68.8M | $38.7M | $19.1M | $23.4M |
| Adjustments For Sharebased Payments | $6.7M | $8.6M | $10.2M | $6.4M | $4.3M | $4.7M | $4.7M | $5.6M | $4.8M | $4.4M |
| Adjustments For Provisions | -$1.8M | $654.0K | $999.0K | $1.1M | $1.9M | $2.8M | $2.1M | $825.0K | $341.0K | -$79.0K |
| Adjustments For Gains Losses On Interest Rate And Exchange Differences On Derivatives | 115,300,000.0% | 860,500,000.0% | -1,368,500,000.0% | -1,727,600,000.0% | -1,005,800,000.0% | 46,900,000.0% | 5,150,400,000.0% | 3,867,900,000.0% | -2,174,500,000.0% | 1,768,600,000.0% |
| Adjustments For Gains Losses On Change In Fair Value Of Derivatives | -$21.8M | $11.2M | $9.7M | $29.3M | -$5.2M | -$4.0M | -$50.0M | -$40.9M | $17.9M | -$25.9M |
| Adjustments For Finance Costs | $68.3M | $16.4M | $83.1M | $75.6M | $47.7M | $62.7M | $40.2M | $53.4M | $44.7M | $43.8M |
| Adjustments For Fair Value Gains Losses | $23.4M | -$10.6M | $3.0M | $4.3M | -$1.1M | $325.0K | -$13.4M | -$4.3M | -$14.0M | -$11.3M |
| Adjustments For Depreciation Expense | $223.8M | $198.3M | $188.8M | $167.3M | $140.6M | $173.2M | $153.0M | $150.1M | $126.8M | $103.8M |
| Adjustments For Decrease Increase In Inventories | $3.1M | -$12.4M | $45.4M | -$102.8M | -$30.2M | $10.0M | -$41.5M | -$4.1M | -$22.3M | -$9.3M |
| Adjustments For Amortisation Expense | $2.3M | $1.7M | $2.3M | $1.6M | $1.3M | $1.2M | $1.2M | $936.0K | $701.0K | $585.0K |
| Gains Losses On Net Monetary Position | $2.4M | $28.8M | -$2.1M | $11.5M | $12.1M | $92.4M | -$25.2M | $0.00 | $0.00 | |
| Issued Capital | $167.1M | $167.1M | $167.1M | $183.6M | $183.6M | $183.6M | $183.6M | $183.6M | $183.6M | |
| Paymentsof Derivative Financial Instruments | $32.0K | -$118.0K | -$2.4M | $1.7M | -$1.5M | $2.6M | $9.5M | $3.7M | $18.7M |
Most recent annual filing with the SEC: April 25, 2025
Data sourced from SEC EDGAR public filings as of August 6, 2026.